Navigation Links
Obesity Common in Children with Heart Disease
Date:11/1/2007

PHILADELPHIA, Nov. 1 /PRNewswire-USNewswire/ -- Obesity is common in children with heart disease, a population already at increased risk of a shortened life expectancy.

More than 25 percent of children with congenital and acquired heart disease are overweight or obese, say researchers from The Children's Hospital of Philadelphia and Children's Hospital, Boston in a study released in the current issue of Pediatrics. While this 25 percent prevalence is similar to the rate found in the general population, the researchers stress that health risks from obesity are added to the children's separate risks from their underlying heart disease.

Activity restrictions, whether or not they are recommended by physicians, may play a role in the development of obesity in this patient group, say the research team, adding that doctors may need to counsel families on safe and appropriate exercise routines for their children.

"Children with congenital heart disease may have unique risk factors which may contribute to the development of obesity," said Nelangi M. Pinto, M.D., a pediatric cardiologist now at University of Utah formerly of The Children's Hospital of Philadelphia where the research was conducted and primary investigator of this study. "The long-term impact of superimposed obesity on children with heart disease is unknown but is likely to increase morbidity and mortality as it does in adults with heart disease."

The Children's Hospital of Philadelphia clinicians collaborated with researchers from Children's Hospital Boston, to review the medical records from a sample of 2,921 patients between ages six and 19 years of age who visited one of the hospitals for cardiology outpatient care in 2004. Of the 2,921 samples, 1,523 children had either acquired or congenital heart disease.

Roughly half of the sample who had no significant heart disease constituted the control group in the study. The rate of overweight and obesity in these con
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
3. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
4. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
5. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
6. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
7. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
8. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
9. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
10. One-Third of Patients Discontinue Common Breast Cancer Therapy
11. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a b...tary antibodies for the treatment of cancer, infla...at Bayer Schering Pharma AG has exercised its opti...eement entered into on January 12, 2009 to develop...mors. ,, Under the terms of the agreement, Baye...
(Date:11/30/2009)...ewswire/ -- Microban International, Ltd., the glob...tion, is pleased to announce their exclusive North...est U.S. manufacturer and distributor of ceramic t... two new lines of ceramic tile with OutStand Techn...g silver based technology, in order to create a li...
(Date:11/30/2009)...Newswire-FirstCall/ -- Nektar Therapeutics (Nasdaq...e Masuoka, M.D. to Senior Vice President and Chief...y to Nektar,s President and Chief Executive Office...g leadership and highly effective clinical develop...advancing Nektar,s proprietary clinical pipeline, ...
Breaking Medicine Technology:Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3Midlife Heart Risk Factors Linked to Later Dementia 53613 1Midlife Heart Risk Factors Linked to Later Dementia 53613 2Midlife Heart Risk Factors Linked to Later Dementia 53613 3CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 1CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 2CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 3CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 4More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 1More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 3More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 4
...BRISBANE, Australia, May 8 Implicit Bioscience Lt...tion of a manufacturing contract to support the ne...C14, a clinical-stage monoclonal antibody for acut...ty profile in over 150 patient exposures, and init...ly-ventilated patients has provided a clear ration...
...Isolagen(TM), Inc. (NYSE Amex: ILE ) today annou...ration ("FDA") has completed its initial review of...") related to its Nasolabial Fold/Wrinkles product...) the BLA for full review. , , In a communication...ed that it had completed its initial review of the...
Other Medicine Technology:CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 2CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 3CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 4Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3
(Date:11/30/2009)...ty is attempting to dispel the notion that all U.S...tients home pregnant with multiples. While they w...priority is health and safety. In addition, they ...on a country’s healthcare system. , ...any patients and doctors in the U.K. worry that cr...
(Date:11/30/2009)...Results of a randomized, controlled clinical trial...ological Society of North America (RSNA) reveal th... in arteries that supply blood to the legs and oth...ent coronary artery disease. ,, Peripheral art...ion of fat, cholesterol and other substances, buil...
(Date:11/30/2009)...High-frequency ultrasound with elastography can he... conditions, according to a study presented today ...of North America (RSNA). ,, "High-frequency ult...rove the efficiency of skin cancer diagnosis," sai... of the Department of Radiology at the University ...
(Date:11/30/2009)...A study presented today at the annual meeting of t...vealed that MRI is a highly accurate means of iden...tening and increasingly common condition that is t...d after giving birth. ,, "Due to the increase ...e scarring on the uterine wall, coupled with women...
(Date:11/30/2009)...ire-FirstCall/ -- VitaminSpice (OTC Bulletin Board...Bill" R. Fields to the Board of Directors. ,, M...source Co. Ltd. Mr. Fields is a Director of Lexmar...d as Chairman and Chief Executive Officer of Facto...nd Chief Executive Officer of Hudson,s Bay Company...
Breaking Medicine News(10 mins):Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3Health News:Special Ultrasound Accurately Identifies Skin Cancer 2Health News:Special Ultrasound Accurately Identifies Skin Cancer 3Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 2Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 3Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2
...eportedly revealed that being a misfit in her grou...// The 30-year-old actress has further insist...lane, has saved her from the temptations of illega...ever taken coke, Femalefirst quoted her, as saying...
That snacking in-between meals plays a major role in causing obesity is well-known. It has now emerged that obese children are also more prone to fall a prey to dental decay. //
...dreas Meyer-Lindenberg, M.D., Ph.D., NIMH Genes Co...one oxytocin weeks the brain’s fear centre. When a...tutes of Health's (NIH) & National Institute of Me... response to the fear stimuli. Previous analy...
..., Stanford University as reported in the Journal H...d had regular check ups with their physicians show...had little trust on the treatment given by their d...at in African-Americans, the poor and the uninsure...
...g to a controversial guidance it has been proposed...ld have to forgo treatment on the NHS//. This c...other agencies. As the National Institute for Heal...e self-inflicted cause of the condition will influ...
...r drug which is approved for treatment to breast c...than 25% of women with breast cancer// produce thi...reast cancer very aggressive and resist chemothera...s but the drug is very costly and the Herceptin tr...
Other Medicine News:Health News:Oxytocin Boosts Trust and Reduces Fear. 2
...is a plastic device that fits over a standard micr...d with a minimum amount of reagent. , , This syst...rplate and slide. The liquid stays in the gap unt...ts pressure then causes the previous reagent to be...
Point-of-Care Manager (PDM)
Instra-Glide Soak®
Shandon Excelsior ES™ Tissue Processor
Medicine Products: